The malabsorption syndrome market is comprised of various treatment products offered for celiac disease, Crohn's disease, short bowel syndrome, radiation injury, pancreatic insufficiency, bariatric surgeries, and liver disease. Malabsorption syndrome occurs when the small intestine is unable to absorb enough nutrients, vitamins, and minerals from food due to various diseases and conditions affecting the gastrointestinal tract. Treatments include enzyme replacement therapy, vitamin and mineral supplements, prebiotics and probiotics, dietary changes, and medication.
The Malabsorption Syndrome Market is estimated to be valued at US$ 3.42 Bn in 2024 and is expected to exhibit a CAGR of 6.8% over the forecast period 2024-2031.
Key Takeaways
Key players operating in the malabsorption syndrome market are AbbVie Inc., Immunogen X, LLC, Astra Zeneca, ImmusanT, Inc.,Ritter Pharmaceuticals. AbbVie Inc. holds a major share in the market and offers treatments such as Humira and Stelara.
The growing prevalence of diseases causing malabsorption syndrome such as celiac disease and crohn's disease is a major factor driving the demand for malabsorption treatments. According to statistics, around 1% of the global population suffers from celiac disease.
Technological advancements have led to the development of targeted therapies, diagnostic tests, and personalized treatments. Companies are investing heavily in R&D to develop new drugs, enzymes, vaccines, and gene therapies to better manage malabsorption.
Market Trends
- Increasing adoption of enzyme replacement therapy: Enzyme supplements containing pancreatin, pancrelipase, etc. help breakdown proteins, carbs, and fats which people with pancreatic insufficiency cannot breakdown. Their use is steadily rising.
- Growth in demand for nutritional supplements: Products containing vitamins A, D, E, K, B12, iron, calcium, magnesium are widely used to meet nutritional needs of people with malabsorption. Tailored supplements address individual deficiencies.
Market Opportunities
- Developing new drug formulations: R&D in advanced drug delivery systems like nanoparticles, microspheres can offer improved treatment adherence and outcomes.
- Expanding into emerging markets: While North America and Europe dominate currently, focus on Asia Pacific and Latin America can tap high patient population and drive future growth.
Impact Of COVID-19 On Malabsorption Syndrome Market Growth
The COVID-19 pandemic has significantly impacted the growth trajectory of the malabsorption syndrome market. During the initial outbreak and peak of infections across regions, limited resources and concentrated efforts of healthcare systems towards COVID affected patients negatively impacted the diagnosis and management of malabsorption syndrome patients. Restrictions on non-essential medical visits and hospitalizations led to delays in consultations and treatments. However, with increasing availability of teleconsultation facilities, the impact was mitigated to some extent for stable patients requiring routine follow-ups.
As the pandemic spread, supply chain disruptions affected the production and distribution of important drugs and nutritional supplements used in malabsorption syndrome management. Shortage of raw materials and logistical challenges impacted the consistent supply to patients. This imbalance in demand-supply equilibrium affected patient compliance and clinical outcomes to a certain degree.
As vaccination drives progress and cases decline in many regions globally, healthcare services are rebuilding capacities. Patients are gradually resuming visits for malabsorption syndrome management. Drugmakers too have overcome early hurdles and restored production levels. With accelerated research on COVID therapies, the sector is expected to bounce back faster than anticipated earlier. Telehealth is also expected to continue complementing in-person care delivery, especially for rural populations.
Geographical Regions With Highest Malabsorption Syndrome Market Value
North America dominates the Malabsorption Syndrome Market in terms of value, given the high diagnosis and treatment rates supported by good healthcare infrastructure and reimbursement scenario. The United States accounts for the major share within the region owing to presence of key market players and large patient pool affected by different types of malabsorption disorders like celiac disease and tropical sprue.
Europe follows North America with a significant market presence led by countries such as Germany, United Kingdom and France where awareness levels are rising. Growing geriatric population prone to gastrointestinal issues also supports the regional market growth. However, Asia Pacific is emerging as the fastest growing regional market backed by improving access to healthcare in India and China along with rising incidences of intestinal diseases and gut dysbiosis ingeneral population.
Fastest Growing Region For Malabsorption Syndrome Market
Asia Pacific region holds immense opportunities for malabsorption syndrome market players and is expected to witness the fastest value growth during the forecast period. Factors such as increasing healthcare spending per capita, government focus on strengthening public healthcare through various programs, rising medical tourism and presence of contract manufacturing bases are attracting several global brands to expand in Asia Pacific markets.
At the same time, prevalence of tropical enteropathies, changes in dietary patterns exposing population to maldigestion and malabsorption risks, wider reach of new diagnostic technologies are enhancing the disease detection rates. With economic development, there is growing awareness among patients regarding available treatment options. This is supporting the demand for innovative drugs and supplemental nutrition products in Asia Pacific's malabsorption syndrome market.
Get more insights on this topic: https://www.trendingwebwire.com/malabsorption-syndrome-market-is-estimated-to-witness-high-growth-owing-to-advancements-in-immuno-absorption-therapies/
Author Bio:
Money Singh is a seasoned content writer with over four years of experience in the market research sector. Her expertise spans various industries, including food and beverages, biotechnology, chemical and materials, defense and aerospace, consumer goods, etc. (https://www.linkedin.com/in/money-singh-590844163 )
What Are The Key Data Covered In This Malabsorption Syndrome Market Report?
:- Market CAGR throughout the predicted period
:- Comprehensive information on the aspects that will drive the Malabsorption Syndrome Market's growth between 2024 and 2031.
:- Accurate calculation of the size of the Malabsorption Syndrome Market and its contribution to the market, with emphasis on the parent market
:- Realistic forecasts of future trends and changes in consumer behaviour
:- Malabsorption Syndrome Market Industry Growth in North America, APAC, Europe, South America, the Middle East, and Africa
:- A complete examination of the market's competitive landscape, as well as extensive information on vendors
:- Detailed examination of the factors that will impede the expansion of Malabsorption Syndrome Market vendors
FAQ’s
Q.1 What are the main factors influencing the Malabsorption Syndrome Market?
Q.2 Which companies are the major sources in this industry?
Q.3 What are the market’s opportunities, risks, and general structure?
Q.4 Which of the top Malabsorption Syndrome Market companies compare in terms of sales, revenue, and prices?
Q.5 Which businesses serve as the Malabsorption Syndrome Market’s distributors, traders, and dealers?
Q.6 How are market types and applications and deals, revenue, and value explored?
Q.7 What does a business area’s assessment of agreements, income, and value implicate?
*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it
Comments
0 comment